ICBM 2027

Menu

Call for Symposia Now Open

Call for Symposia

Looking to submit an individual paper or poster instead?

If you are submitting an individual paper or poster, please visit the Call for Abstracts page.

Visit the Call for Abstracts page →

The Transformative Power of Behavioral Medicine: Time to Act

Submit Your Research to ICBM 2027

The International Congress of Behavioral Medicine (ICBM 2027) invites researchers, clinicians, educators, practitioners, and policymakers to submit abstracts presenting original research, innovative methodologies, and advances in behavioral medicine.

Join an international community dedicated to advancing behavioral medicine through scientific excellence, interdisciplinary collaboration, and the translation of research into clinical practice, public health, and policy. Accepted abstracts will contribute to a dynamic scientific program showcasing the latest developments from across the field.

All submissions should present original, scientifically rigorous work with clearly defined objectives, appropriate methodology, completed results, and evidence-based conclusions. All abstracts will undergo peer review by the ICBM 2027 Scientific Program Committee.

We look forward to receiving your submission and welcoming you to ICBM 2027.

Download the Symposia Submission Guidelines Here

Important Dates

Symposia Submission DeadlineJanuary 8, 202723:59 GMT+8
Abstract Acceptance NotificationFebruary 12, 2027
Early Bird Registration OpensNovember 2, 2026
Early Bird Registration DeadlineMarch 19, 202723:59 GMT+8
Regular Registration OpensMarch 20, 2027
Congress DatesJuly 28–31, 2027

Symposia Submission is NOW OPEN

Symposia Submission Portal
Download the Symposia Abstract Submission Template Here

Symposia Submission Guidelines

General Requirements 

  • All submissions must be made electronically through the ICBM 2027 Symposia Submission Portal.
  • The submitting author serves as the primary contact for all correspondence and is responsible for:
    • Ensuring that all co-authors have reviewed and approved the submission prior to submission;
    • Communicating all correspondence and decisions from the Scientific Program Committee to co-authors; and
    • Ensuring that all submission information is accurate at the time of submission. 
  • Authors may indicate a preferred Congress track and presentation format where applicable. The final allocation of abstracts to tracks, presentation formats, and sessions rests with the Scientific Program Committee. 

Symposia 

Maximum Symposia abstract length: 400 words, excluding: 

  • Title
  • Author names
  • Institutional affiliations 

Symposia proposals should include: 

  • The overall objectives of the Symposia;
  • A brief overview of the session theme;
  • A concise narrative description of each presentation; and
  • An explanation of how the individual presentations contribute to a coherent session. 

Additional Symposia Information: 

  • Symposia are 90 minutes in duration.
  • A Symposia typically consists of a Chair, four to five presenters (including the Chair), and a Discussant.
  • Authors included within a Symposia proposal may elect to have their individual abstract considered independently should the Symposia not be accepted.
  • Empirically based symposia presenting original research or integrative scientific work are encouraged. A limited number of symposia addressing scientific training, health policy, or the interface between science and professional practice may also be considered. 
  1. Submit the Symposia abstract. Log in to the Symposia Submission Portal and enter the Symposia-level abstract. The portal automatically saves this as a draft under “My Submissions/Drafts”. 

  2. Download the Symposia Presenter Abstract Template. Download the “ICBM 2027 Symposia Abstract Submission Template” (Word document) using the download button above, or from within the portal.
     
  3. Complete the template. Fill in the following for each presenter (including yourself, if presenting), plus the Discussant’s contact details if applicable:  
    • Fill in Contact Details 
    • Abstract Title, Authors, and Affiliations 
    • Abstract Body 
    • Independent Submission Preference (required) — Each presenter must indicate whether they consent to their abstract being considered as a standalone individual submission if the symposium is not accepted. Please confirm this preference directly with each presenter before completing this section on their behalf. 

  4. Upload and finalize. Return to your saved draft, upload the completed Word document, review everything together, and submit. 

Important: 

  • All fields must be completed for every presenter. Incomplete submissions will not be accepted.
  • Confirm with every presenter that their details are accurate, and they agree to the submission 

Required Abstract Structure 

Abstracts must be organized using the following headings: 

  • Background: Briefly describe the scientific, clinical, or public health context of the study and the rationale for conducting the research.
  • Purpose: Clearly state the study objective(s), research question(s), or hypothesis(es).
  • Method: Summarize the study design, participants, procedures, measures, and analytical approach.
  • Results: Present the principal findings with sufficient detail to support the conclusions. Whenever possible, include quantitative or qualitative results rather than statements indicating that results will be presented.
  • Conclusions: State the implications, significance, or potential applications of the findings for research, clinical practice, public health, or policy. 

Formatting Guidelines 

  • Abstracts must be written in English.
  • Abstracts must be submitted using the required headings: Background, Purpose, Method, Results, and Conclusions. 
  • Use clear, concise, and scientifically appropriate language. 
  • Standard scientific abbreviations may be used without definition. Non-standard abbreviations must be defined at first use.
  • Use Arabic numerals for numbers, except when they appear at the beginning of a sentence.
  • Carefully proofread abstracts for grammar, spelling, and clarity prior to submission.
  • Once the abstract submission deadline has passed, submitted abstracts cannot be revised or replaced. 

Additional Guidance 

  • Abstracts should report completed analyses. Abstracts stating only that “results will be discussed” or “data will be presented” may not be accepted.
  • Commercial product names should be avoided; use generic names whenever possible.
  • References, tables, and figures are not permitted.
  • Abstracts should not contain identifying information within the body of the abstract if peer review is conducted anonymously. 

Life Course and Population Health 

  • Child, Adolescent, and Family Health
  • Aging and Healthy Longevity
  • Occupational Health and Well-being
  • Women’s, Men’s, and Reproductive Health 

Prevention, Behavior Change, and Intervention Science 

  • Behavior Change Theory and Interventions
  • Prevention Across the Care Continuum
  • Systems, Community, and Network Approaches
  • Intervention Effectiveness and Health Outcomes
  • Digital and Technology-Enabled Interventions 

Education, Communication, and Implementation 

  • Education, Training, and Professional Development
  • Health Education, Promotion, and Risk Communication
  • Shared Decision-Making and Patient Engagement
  • Health Systems, Policy, Dissemination, and Implementation Science 

Health Equity and Social Determinants 

  • Health Equity and Social Determinants of Health
  • Sexual, Gender, and Other Priority Populations
  • Community Engagement and Public Involvement
  • Patients, Public, Policy, and Practice 

Mechanisms of Health and Behavior 

  • Biological Mechanisms
  • Psychological and Behavioral Mechanisms
  • Social and Environmental Mechanisms
  • Theoretical Models and Frameworks
  • Placebo, Nocebo, and Treatment Context

Chronic Disease Prevention and Management 

  • Diabetes
  • Cardiovascular Diseases
  • Cancer Prevention and Control
  • Chronic Pain and Persistent Conditions
  • Multimorbidity and Complex Care 

Infectious Diseases and Global Health 

  • Infectious Diseases
  • HIV/AIDS
  • COVID-19 and Pandemic Preparedness
  • Tropical and Neglected Diseases
  • Vaccination and Prevention Behaviors 

Emerging Topics 

  • Digital Health, AI, and Wearables
  • Climate Change and Planetary Health
  • Big Data and Data Science
  • Behavioral Economics
  • Co-production and Patient Engagement 

Important Policies

  • By submitting an abstract, authors confirm that the work is original, accurately represents the research conducted, and has not been previously published in a peer-reviewed journal.
  • Authors may use artificial intelligence (AI) tools to assist with language editing or formatting. Authors remain fully responsible for the accuracy, originality, scientific integrity, and authorship of all submitted content. AI tools must not be listed as authors.
  • Submission of an abstract grants ICBM permission to publish accepted abstracts in congress publications and proceedings.
  • Each individual may be listed as the presenting author on a maximum of two (2) abstract submissions. There is no limit on co-authorship.
  • Multiple submissions derived from the same dataset are permitted only where each abstract represents a distinct scientific contribution that could reasonably be developed into a separate peer-reviewed publication. Duplicate, overlapping, or fragmented submissions may be rejected. 
  • At least one presenting author for each accepted abstract must register for the congress and pay the applicable registration fee by the Early Bird Registration Deadline. 
  • Early Bird Registration Deadline: March 19, 2027 (23:59 GMT+8)
  • Registration by the deadline is required for the abstract to:
    • Be included in the official congress publications; and
    • Be scheduled for presentation. 
  • Each presenting author is responsible for their own congress registration and associated fees.
  • If a presenting author is unable to attend, they should arrange for an eligible co-author to present the work in person, subject to congress policies.
  • Failure to register by the required deadline may result in removal of the abstract from the scientific program and congress publications. 

All submissions will undergo peer review and will be evaluated according to the following criteria: 

  • Scientific merit and innovation
  • Methodological quality and rigor
  • Significance and potential impact
  • Relevance to behavioral medicine and congress theme
  • Clarity of presentation 

 The Scientific Program Committee reserves the right to determine the final presentation format, session allocation, and Congress track for all accepted submissions. All decisions of the Committee are final. 

Individual Scientific Abstracts 

Abstracts submitted as individual scientific presentations should be based on empirical research and report completed findings. Abstracts containing statements such as “Results will be presented” or “Results will be discussed” are unlikely to be accepted. 

Definition of Empirical Research  

Empirical research includes, but is not limited to: 

  • Primary quantitative research (e.g., observational studies, clinical trials, experimental studies);
  • Primary qualitative research (e.g., interviews, focus groups, ethnographic studies);
  • Mixed-methods research; and
  • Secondary research that applies recognized and systematic methodologies, including systematic reviews, meta-analyses, meta-syntheses, scoping reviews, and other evidence synthesis approaches. 

Empirical submissions should employ appropriate and accepted methods for data collection, analysis, and interpretation. 

Traditional literature reviews that do not use a recognized evidence synthesis methodology will not be considered empirical research. Such work may, however, be appropriate for courses, panels, or symposia where relevant. 

The Scientific Program Committee is committed to maintaining the highest standards of scientific integrity and ethical conduct. 

By submitting an abstract, authors confirm that: 

  • The work accurately represents the research conducted;
  • All listed authors have made appropriate scholarly contributions and have approved the submission;
  • All applicable institutional ethics approvals and participant consent requirements have been met, where relevant; and
  • Any financial or other conflicts of interest have been disclosed in accordance with congress requirements. 

Scientific misconduct includes, but is not limited to: 

  • Plagiarism, including presenting another person’s ideas, data, text, or results as one’s own;
  • Fabrication, falsification, or manipulation of data or research findings;
  • Intentional misrepresentation of methods or results;
  • Duplicate or redundant publication or submission; and
  • Other practices that compromise the integrity of the scientific record. 

Where concerns regarding research or publication misconduct arise, the Scientific Program Committee reserves the right to investigate the matter. Authors will be given an opportunity to respond to any concerns in a timely manner. Confirmed misconduct, or failure to respond to requests for clarification, may result in one or more of the following actions: 

  • Rejection of the abstract;
  • Removal of the presentation from the congress program;
  • Retraction of the published abstract; and/or
  • Restriction of future abstract submissions to ICBM. 

Authors who need to withdraw an abstract should notify the Scientific Program Committee in writing as early as possible. 

Failure to present an accepted abstract without prior notification may affect eligibility for future ICBM abstract submissions. 

Exceptions may be considered in circumstances beyond the author’s control, including: 

  • Significant travel disruption (e.g., severe weather);
  • Work-related emergencies; or
  • Personal illness or family medical emergencies. 

Registration fees are subject to the congress cancellation and refund policy. 

Scroll to Top